Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
IL-23 Plasma level measurement in relapsing remitting multiple sclerosis (RRMS) patients compared to healthy subjects.
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.
[Treatment of neuromyelitis optica].
IFNγ Influences Type I Interferon Response and Susceptibility to Theiler's Virus-Induced Demyelinating Disease.
Determinants of sexual dysfunction in women with multiple sclerosis.
Comorbidities at multiple sclerosis diagnosis.
Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis.
Functional brain network analysis using minimum spanning trees in Multiple Sclerosis: An MEG source-space study.
Effects of Multiple Sclerosis on Female Sexuality: A Controlled Study.
Multiple sclerosis in 2013: Novel triggers, treatment targets and brain atrophy measures.
Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination.
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients.
Prevalence and natural history of pain in adults with multiple sclerosis: Systematic review and meta-analysis.
[Good practice in prophylactic care: prophylactic care and professional activation of employees with multiple sclerosis].
Vaccine against autoimmune disease: can helminths or their products provide a therapy?
Relapse of multiple sclerosis in a patient retaining CCR7-expressing T cells in CSF under fingolimod therapy.
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report.
Assessment of urinary incontinence in the women in Eastern Turkey.
Rationale and design of a randomized controlled, clinical trial investigating a comprehensive exercise stimulus for improving mobility disability outcomes in persons with multiple sclerosis.
Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis.
[Optic neuritis--immunological approach to elucidate pathogenesis and develop innovative therapy].
Myelin membrane assembly is driven by a phase transition of myelin basic proteins into a cohesive protein meshwork.
Multiple sclerosis drug fingolimod receives new safety warnings related to cardiovascular risk.
Fingolimod does not enhance cerebellar remyelination in the cuprizone model.
Smoking Beyond Multiple Sclerosis Diagnosis: A Risk Factor Still Worth Modifying.
Pages
« first
‹ previous
…
470
471
472
473
474
475
476
477
478
…
next ›
last »